Precision cancer drug development
Develops new classes of precision cancer drugs with novel mechanisms of action.
Source: LinkedIn company description · Retrieved October 13, 2026
Lantern Pharma is a clinical-stage pharmaceutical company developing precision cancer drugs with novel mechanisms of action.
Lantern identifies patient stratification before enrollment as a challenge in oncology drug development. The company focuses on accelerating personalized cancer therapy development using AI and genomic-based patient stratification.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Develops new classes of precision cancer drugs with novel mechanisms of action.
Source: LinkedIn company description · Retrieved October 13, 2026
Rescues or revitalizes abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 30, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.